Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-19T22:47:57.849Z Has data issue: false hasContentIssue false
  • English
  • Français

Impairment of the Blood-Brain Barrier as an Aetiological Factor in Paranoid Psychosis

Published online by Cambridge University Press:  29 January 2018

Rolf Axelsson ,
Erik Martensson  and
Christer Alling
Rolf Axelsson
Affiliation:
Psychiatric Department III, Lillhagen Hospital, University of Goteborg, S-422 03 Hisings Backa, Sweden
Erik Martensson
Affiliation:
Psychiatric Department III, Lillhagen Hospital, University of Goteborg, Sweden
Christer Alling
Affiliation:
Department of Psychiatry and Neurochemistry, St Jorgen Hospital, University of Goteborg, Sweden
Get access Rights & Permissions [Opens in a new window]

Summary

Possible psychiatric implications of impairment of the blood-brain barrier were studied in 25 patients with paranoid psychosis. Determination of the ratio between the albumin concentrations in cerebrospinal fluid and serum showed increases, indicating impairment of the blood-brain barrier, in seven patients and normal values in 18. The two groups were compared for clinical, pharmacokinetic, neurophysiological and anamnestic variables. The highly significant finding that onset of psychosis had occurred, on average, 20 years earlier in the patients with impairment of the blood-brain barrier than in those without suggests that such impairment might influence the development of psychosis in predisposed individuals.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 141 , Issue 3 , September 1982 , pp. 273 - 281
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Åsberg, M., Montgomery, S. A., Perris, C., Schalling, D. & Sedvall, G. (1978) A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica, Supplement 271.CrossRefGoogle Scholar
Axelsson, R. & Mártensson, E. (1978) Relationship between serum concentration of thioridazine and its main nonconjugated metabolites and the clinical response in thioridazine-treated patients. Current Therapeutic Research, 24, 232–42.Google Scholar
Karlsson, B. & Alling, C. (1980) A comparative study of three approaches to the routine quantitative determination of spinal fluid total proteins. Clinical Chimica Acta, 105, 65–73.Google Scholar
Laurell, C. B. (1972) Electroimmunoassay. Scandinavian Journal of Clinical and Laboratory Investigation, 29, Supplement 124, 21–37.Google Scholar
Meltzer, H. Y. (1979) Biology of schizophrenia subtypes: A review and proposal for method of study. Schizophrenia Bulletin, 5, 460–79.CrossRefGoogle ScholarPubMed
Mártensson, E., Nyberg, G., Axelsson, R. & Serck-Hansen, K. (1975) Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Current Therapeutic Research, 18, 687–700.Google Scholar
Nyberg, G., Axelsson, R. & Mártensson, E. (1978) Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. European Journal of Clinical Pharmacology, 14, 341–50.CrossRefGoogle ScholarPubMed
Nyberg, G., Axelsson, R. & Mártensson, E. (1981) Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients. European Journal of Clinical Pharmacology, 19, 139–48.Google Scholar
Salo, E. J. & Honkavaara, E. I. (1974) A linear single reagent method for determination of protein in cerebrospinal fluid. Scandinavian Journal of Clinical and Laboratory Investigation, 34, 383–8.CrossRefGoogle Scholar
Spitzer, R. L. (ed.) (1980) Diagnostic and Statistical Manual of Mental Disorders (DSM III). Washington: The American Psychiatric Association.Google Scholar
Tibbling, G., Link, H. & Öhman, S. (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scandinavian Journal of Clinical and Laboratory Investigation, 37, 385–90.Google Scholar
Torrey, E. F., Peterson, M. R., Brannon, W. L., Carpenter, W. T., Post, R. M. & van Kammen, D. P. (1978) Immunoglobulins and viral antibodies in psychiatric patients. British Journal of Psychiatry, 132, 342–8.CrossRefGoogle Scholar
Weinberger, D. R., Bigelow, L. B., Kleinman, J. E., Klein, S. T., Rosenblatt, J. E. & Wyatt, R. J. (1980) Cerebral ventricular enlargement in chronic schizophrenia. Archives of General Psychiatry, 37, 11–13.CrossRefGoogle ScholarPubMed
Wieme, R. J. (1959) An improved technique of agar-gel electrophoresis in microscope slides. Clinical Chimica Acta, 4, 317–21.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.